Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Wessale

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Medical Instrumentation|January 1, 1986
Optimization of epicardial electrode size and implant site for reduced sequential pulse defibrillation thresholdsM J Kallok, J D Bourland, W A Tacker, et al.
Circulation|November 30, 2000
Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertensionY Matsumura, T Kuro, Y Kobayashi, et al.
Journal of Cardiovascular Pharmacology|July 1, 1997
Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigsS E Burke, N L Lubbers, G D Gagne, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Increased susceptibility to deoxycorticosterone acetate-salt-induced hypertension in endothelin-B-receptor-deficient ratsY Matsumura, T Kuro, Y Kobayashi, et al.
Journal of Cardiovascular Pharmacology|June 1, 1997
The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley ratsS J Chen, Y F Chen, T J Opgenorth, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 levelT J Opgenorth, J L Wessale, D B Dixon, et al.
European Journal of Pharmacology|February 5, 2000
ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic painM F Jarvis, J L Wessale, C Z Zhu, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Cardiovascular effects and hemodynamic mechanism of action of the novel, nonpeptidic renin inhibitor A-74273 in dogsJ L Wessale, S V Calzadilla, S A Boyd, et al.
Journal of Medicinal Chemistry|September 16, 1994
Nonpeptide renin inhibitors with good intraduodenal bioavailability and efficacy in dogS A Boyd, A K Fung, W R Baker, et al.
Journal of Medicinal Chemistry|September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivityT W von Geldern, A S Tasker, B K Sorensen, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Medical Instrumentation|January 1, 1986
Optimization of epicardial electrode size and implant site for reduced sequential pulse defibrillation thresholdsM J Kallok, J D Bourland, W A Tacker, et al.
Circulation|November 30, 2000
Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertensionY Matsumura, T Kuro, Y Kobayashi, et al.
Journal of Cardiovascular Pharmacology|July 1, 1997
Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigsS E Burke, N L Lubbers, G D Gagne, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Increased susceptibility to deoxycorticosterone acetate-salt-induced hypertension in endothelin-B-receptor-deficient ratsY Matsumura, T Kuro, Y Kobayashi, et al.
Journal of Cardiovascular Pharmacology|June 1, 1997
The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley ratsS J Chen, Y F Chen, T J Opgenorth, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 levelT J Opgenorth, J L Wessale, D B Dixon, et al.
European Journal of Pharmacology|February 5, 2000
ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic painM F Jarvis, J L Wessale, C Z Zhu, et al.
Journal of Cardiovascular Pharmacology|October 1, 1993
Cardiovascular effects and hemodynamic mechanism of action of the novel, nonpeptidic renin inhibitor A-74273 in dogsJ L Wessale, S V Calzadilla, S A Boyd, et al.
Journal of Medicinal Chemistry|September 16, 1994
Nonpeptide renin inhibitors with good intraduodenal bioavailability and efficacy in dogS A Boyd, A K Fung, W R Baker, et al.
Journal of Medicinal Chemistry|September 10, 1999
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 4. Side chain conformational restriction leads to ET(B) selectivityT W von Geldern, A S Tasker, B K Sorensen, et al.
Pageof 4